Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers

被引:44
作者
Buseyne, F
Burgard, M
Teglas, JP
Bui, E
Rouzioux, C
Mayaux, MJ
Blanche, S
Rivière, Y
机构
[1] Inst Pasteur, Unite Virol & Immunol Cellulaire, F-75015 Paris, France
[2] Hop Necker Enfants Malad, Virol Lab, F-75015 Paris, France
[3] Hop Bicetre, INSERM, U292, F-94275 Le Kremlin Bicetre, France
[4] Hop Necker Enfants Malad, Unite Immunol & Hematol, F-75015 Paris, France
关键词
D O I
10.1089/aid.1998.14.1435
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The activities of HIV-specific cytotoxic T lymphocytes (CTLs) were evaluated in 10 HIV-infected children, born to infected mothers who did not receive AZT during pregnancy, CTL activities were present as early as 4 months of age. The five children that progressed to AIDS before 1 year of age had reduced in vivo and in vitro CTL activities, when compared with children who remained AIDS free after 1 year of age. The latter children had weak in vivo activated CTL responses but strong memory CTLs, No relation was found between viral load, lymphocyte populations, and CTL responses between birth and 6 months of age, Between 7 and 12 months old, children with broader in vitro activated CTLs had higher absolute numbers of CD4(+) and CD8(+) T lymphocytes and lower plasma viral load, These data support a beneficial role of CTLs in pediatric HIV infection.
引用
收藏
页码:1435 / 1444
页数:10
相关论文
共 55 条
[31]   Early progression of disease in HIV-infected infants with thymus dysfunction [J].
Kourtis, AP ;
Ibegbu, C ;
Nahmias, AJ ;
Lee, FK ;
Clark, WS ;
Sawyer, MK ;
Nesheim, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) :1431-1436
[32]  
LAMHAMEDICHERRADI S, 1995, AIDS, V9, P421, DOI 10.1097/00002030-199509050-00002
[33]   DEFICIENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC CYTOTOXIC-T CELL RESPONSES IN VERTICALLY INFECTED CHILDREN [J].
LUZURIAGA, K ;
KOUP, RA ;
PIKORA, CA ;
BRETTLER, DB ;
SULLIVAN, JL .
JOURNAL OF PEDIATRICS, 1991, 119 (02) :230-236
[34]  
LUZURIAGA K, 1995, J IMMUNOL, V154, P433
[35]   Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease [J].
Mayaux, MJ ;
Burgard, M ;
Teglas, JP ;
Cottalorda, J ;
Krivine, A ;
Simon, F ;
Puel, J ;
Tamalet, C ;
Dormont, D ;
Masquelier, B ;
Doussin, A ;
Rouzioux, C ;
Blanche, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (08) :606-610
[36]   DETECTION OF PRIMARY CYTOTOXIC LYMPHOCYTES-T SPECIFIC FOR THE ENVELOPE GLYCOPROTEIN OF HIV-1 BY DELETION OF THE ENV AMINO-TERMINAL SIGNAL SEQUENCE [J].
MCCHESNEY, M ;
TANNEAU, F ;
REGNAULT, A ;
SANSONETTI, P ;
MONTAGNIER, L ;
KIENY, MP ;
RIVIERE, Y .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (01) :215-220
[37]   HIGH-FREQUENCY OF GAG-SPECIFIC AND ENVELOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTE PRECURSORS IN CHILDREN WITH VERTICALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
MCFARLAND, EJ ;
HARDING, PA ;
LUCKEY, D ;
CONWAY, B ;
YOUNG, RK ;
KURITZKES, DR .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (04) :766-774
[38]   The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children [J].
Mofenson, LM ;
Korelitz, J ;
Meyer, WA ;
Bethel, J ;
Rich, K ;
Pahwa, S ;
Moye, J ;
Nugent, R ;
Read, J .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1029-1038
[39]   Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection [J].
MunozFernandez, MA ;
Obregon, E ;
Navarro, JQ ;
Borner, C ;
Gurbindo, MD ;
Sampelayo, TH ;
FernandezCruz, E .
PEDIATRIC RESEARCH, 1996, 40 (04) :597-602
[40]  
PACHL C, 1995, J ACQ IMMUN DEF SYND, V43, P1